Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Saffer Promoted to President of OmniViz; BD Exec Pierre Cassigneul Goes to Stone Bridge Consulting; David McGee Leaves LSBC; and Others

NEW YORK, June 18 - Jeffrey Saffer has been appointed president of OmniViz, the genomic visualization software company said today.

 

Saffer has been chief technology officer of the company since its spinoff from Battelle in 2000, and will continue in this role.

 

Prior to joining the Maynard, Mass. startup, Saffer was manager of the molecular biosciences department at Pacific Northwest National Laboratory, which is managed by Battelle. AT PNNL, he developed the gene expression visualization techniques that led to the development of the OmniViz software and the spinout of the company.  Saffer has also worked at the Jackson Laboratory and the NCI Laboratory of Biochemistry.


 

Pierre Cassigneul, a veteran of the diagnostics industry, has been appointed operating partner of biopharma and bio-IT consulting firm StoneBridge management, the Pittstown, N.J. firm said Tuesday.

 

Cassigneul comes to the firm from Becton Dickinson, where he was vice president of diabetes management.

Previously, he was senior vice president of Bayer, and general manager of the company's diabetes self-testing arm. He has also served in leadership roles of Ortho Diagnostic Systems' AIDS and hepatitis business unit, and Abbott Laboratories; and held a market research position at Eurequip in Paris.


 

Todd Edwards has been appointed field technical specialist at Protedyne, the lab automation equipment provider said Tuesday.

 

Edwards will cover the western US, and will work with customers to implement the company's Protocol for Automation, a way to define a company's automation needs and how to meet them.

 

Edwards comes to Protedyne from Lawrence Livermore National Laboratory, where he was a post-doctoral researcher in Joanna Albala's lab, developing automated techniques for protein expression and purification. He has also worked as an assistant professor at WhitmanCollege department of physics.


 

David McGee, a co-founder of Large Scale Biology and executive vice president, is leaving the company, LSBC said June 13 in announcing a restructuring.

 

McGee will "pursue consulting in the biotechnology field," the company said.


 

Willem 'Pim' Stemmer has joined the scientific advisory board of Nuevolution, the Copenhagen, Denmark drug discovery company said June 12.

 

Stemmer co-founded Avidia, a company that performs directed evolution of antibody-like products, earlier this year. He also founded Maxygen in 1997, to market his molecular breeding DNA recombination and functional selection technology to life sciences and agriculture.   These companies stem from Stemmer's invention in 1993 of DNA shuffling technology, when he was a scientist at Affymax Research Institute. Stemmer previously worked as a research scientist at Hybritech, and in 1985 founded Genetic Designs, which performed phage display, codon-based synthesis and E. coli antibody expression.


 

Michael Raymont has been appointed vice president of technology and industry support for Canada's National Research Council (NRC), the council said June 12.

 

Additionally, Peter Hackett, the NRC's vice president of research and technology development, has now been put in charge of its life sciences and information technology arm.

 

These appointments come as the NRC reorganizes. The technology and industry support portfolio that Raymont oversees now includes under its umbrella the NRC's Research Assistance Program (NRC-IRAP), which is designed to help small- and medium-sized research companies in Canada; as well as the NRC Canada Institute for Scientific and Technical Information (NRC-CISTI); and NRC's Technology Centers for Surface Transportation and Hydraulics.

 

Additionally, Hacket will oversee the NRC's five biotechnology institutes, including theBiotechnology Research Institute (NRC-BRI), the NRC Institute for Biological Sciences (NRC-IBS), the NRC Plant Biotechnology Institute (NRC-PBI), the NRC Institute for Biodiagnostics (NRC-IBD), the NRC Institute for Marine Biosciences (NRC-IMB) and the associated genomics and health initiative.   Hackett also oversees the NRC Steacie Institute for Molecular Sciences (NRC-SIMS), the NRC National Institute for Nanotechnology (NINT), the NRC Institute for National Measurement Standards (NRC-INMS), the NRC Institute for Microstructural Sciences (NRC-IMS) and the NRC Institute for Information Technology (NRC-IIT).

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.